Literature DB >> 25950843

Beyond indigestion: emerging roles for lysosome-based signaling in human disease.

Shawn M Ferguson1.   

Abstract

Lysosomes are becoming increasingly recognized as a hub that integrates diverse signals in order to control multiple aspects of cell physiology. This is illustrated by the discovery of a growing number of lysosome-localized proteins that respond to changes in growth factor and nutrient availability to regulate mTORC1 signaling as well as the identification of MiT/TFE transcription factors (MITF, TFEB and TFE3) as proteins that shuttle between lysosomes and the nucleus to elicit a transcriptional response to ongoing changes in lysosome status. These findings have been paralleled by advances in human genetics that connect mutations in genes involved in lysosomal signaling to a broad range of human illnesses ranging from cancer to neurological disease. This review summarizes these new discoveries at the interface between lysosome cell biology and human disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25950843      PMCID: PMC4529762          DOI: 10.1016/j.ceb.2015.04.014

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  95 in total

1.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

2.  Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin.

Authors:  Kota Saito; Yasuhiro Araki; Kenji Kontani; Hiroshi Nishina; Toshiaki Katada
Journal:  J Biochem       Date:  2005-03       Impact factor: 3.387

3.  RagA, but not RagB, is essential for embryonic development and adult mice.

Authors:  Alejo Efeyan; Lawrence D Schweitzer; Angelina M Bilate; Steven Chang; Oktay Kirak; Dudley W Lamming; David M Sabatini
Journal:  Dev Cell       Date:  2014-04-24       Impact factor: 12.270

4.  A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

Authors:  Brian C Grabiner; Valentina Nardi; Kıvanc Birsoy; Richard Possemato; Kuang Shen; Sumi Sinha; Alexander Jordan; Andrew H Beck; David M Sabatini
Journal:  Cancer Discov       Date:  2014-03-14       Impact factor: 39.397

5.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.

Authors:  Jinyan Du; Hans R Widlund; Martin A Horstmann; Sridhar Ramaswamy; Ken Ross; Wade E Huber; Emi K Nishimura; Todd R Golub; David E Fisher
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

6.  Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.

Authors:  Ingrid E Scheffer; Sarah E Heron; Brigid M Regan; Simone Mandelstam; Douglas E Crompton; Bree L Hodgson; Laura Licchetta; Federica Provini; Francesca Bisulli; Lata Vadlamudi; Jozef Gecz; Alan Connelly; Paolo Tinuper; Michael G Ricos; Samuel F Berkovic; Leanne M Dibbens
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

7.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

8.  Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Authors:  Nikhil Wagle; Brian C Grabiner; Eliezer M Van Allen; Eran Hodis; Susanna Jacobus; Jeffrey G Supko; Michelle Stewart; Toni K Choueiri; Leena Gandhi; James M Cleary; Aymen A Elfiky; Mary Ellen Taplin; Edward C Stack; Sabina Signoretti; Massimo Loda; Geoffrey I Shapiro; David M Sabatini; Eric S Lander; Stacey B Gabriel; Philip W Kantoff; Levi A Garraway; Jonathan E Rosenberg
Journal:  Cancer Discov       Date:  2014-03-13       Impact factor: 39.397

9.  The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.

Authors:  Ming Yan; Marie-Claude Gingras; Elaine A Dunlop; Yann Nouët; Fanny Dupuy; Zahra Jalali; Elite Possik; Barry J Coull; Dmitri Kharitidi; Anders Bondo Dydensborg; Brandon Faubert; Miriam Kamps; Sylvie Sabourin; Rachael S Preston; David Mark Davies; Taren Roughead; Laëtitia Chotard; Maurice A M van Steensel; Russell Jones; Andrew R Tee; Arnim Pause
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

10.  DEPDC5 mutations in genetic focal epilepsies of childhood.

Authors:  Dennis Lal; Eva M Reinthaler; Julian Schubert; Hiltrud Muhle; Erik Riesch; Gerhard Kluger; Kamel Jabbari; Amit Kawalia; Christine Bäumel; Hans Holthausen; Andreas Hahn; Martha Feucht; Birgit Neophytou; Edda Haberlandt; Felicitas Becker; Janine Altmüller; Holger Thiele; Johannes R Lemke; Holger Lerche; Peter Nürnberg; Thomas Sander; Yvonne Weber; Fritz Zimprich; Bernd A Neubauer
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

View more
  32 in total

Review 1.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

Review 2.  C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease.

Authors:  Joseph Amick; Shawn M Ferguson
Journal:  Traffic       Date:  2017-03-23       Impact factor: 6.215

Review 3.  Neuronal lysosomes.

Authors:  Shawn M Ferguson
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

4.  Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.

Authors:  Sophia Gayle; Sean Landrette; Neil Beeharry; Chris Conrad; Marylens Hernandez; Paul Beckett; Shawn M Ferguson; Talya Mandelkern; Meiling Zheng; Tian Xu; Jonathan Rothberg; Henri Lichenstein
Journal:  Blood       Date:  2017-01-19       Impact factor: 22.113

Review 5.  Recent Insights Into the Pathogenic Mechanism of Pancreatitis: Role of Acinar Cell Organelle Disorders.

Authors:  Anna S Gukovskaya; Fred S Gorelick; Guy E Groblewski; Olga A Mareninova; Aurelia Lugea; Laura Antonucci; Richard T Waldron; Aida Habtezion; Michael Karin; Stephen J Pandol; Ilya Gukovsky
Journal:  Pancreas       Date:  2019-04       Impact factor: 3.327

6.  Protein kinase C controls lysosome biogenesis independently of mTORC1.

Authors:  Yang Li; Meng Xu; Xiao Ding; Chen Yan; Zhiqin Song; Lianwan Chen; Xiahe Huang; Xin Wang; Youli Jian; Guihua Tang; Changyong Tang; Yingtong Di; Shuzhen Mu; Xuezhao Liu; Kai Liu; Ting Li; Yingchun Wang; Long Miao; Weixiang Guo; Xiaojiang Hao; Chonglin Yang
Journal:  Nat Cell Biol       Date:  2016-09-12       Impact factor: 28.824

Review 7.  Phosphoinositide conversion in endocytosis and the endolysosomal system.

Authors:  Alexander Wallroth; Volker Haucke
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

8.  AKT inhibition-mediated dephosphorylation of TFE3 promotes overactive autophagy independent of MTORC1 in cadmium-exposed bone mesenchymal stem cells.

Authors:  Huifeng Pi; Min Li; Lingyun Zou; Min Yang; Ping Deng; Tengfei Fan; Menyu Liu; Li Tian; Manyu Tu; Jia Xie; Mengyan Chen; Huijuan Li; Yu Xi; Lei Zhang; Mindi He; Yonghui Lu; Chunhai Chen; Tao Zhang; Zheng Wang; Zhengping Yu; Feng Gao; Zhou Zhou
Journal:  Autophagy       Date:  2018-10-20       Impact factor: 16.016

Review 9.  Mitochondria and Cancer.

Authors:  Wei-Xing Zong; Joshua D Rabinowitz; Eileen White
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

Review 10.  Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease.

Authors:  Mark L Schultz; Kelsey L Krus; Andrew P Lieberman
Journal:  Brain Res       Date:  2016-03-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.